Sec. 28.5. (a) This section applies to an individual contract or a group contract that is entered into, amended, or renewed after June 30, 2023.
(b) As used in this section, "wearable cardioverter defibrillator" means a device that:
(1) is worn externally on an individual's body;
(2) continually monitors and analyzes the individual's heart rhythm; and
(3) delivers a shock to the heart when an abnormal heart rhythm is detected.
(c) An individual contract or a group contract must provide coverage for a wearable cardioverter defibrillator, including the cost of the wearable cardioverter defibrillator, any necessary accessory, and ongoing monitoring services.
(d) The coverage required under subsection (c) must be in accordance with a:
(1) local coverage determination; or
(2) national coverage determination;
as defined in 42 U.S.C. 1395ff(f) for Medicare purposes.
(e) The coverage required by this section may not be subject to an annual or lifetime limitation.